The 2026/2027 UK Flu Vaccination Programme: What General Practices Need to Know
The national flu immunisation programme for 2026/27 has now been confirmed, and while much of the framework remains familiar, there are important operational details for primary care teams to plan around. With winter pressures showing no signs of easing, high flu vaccine uptake across all eligible groups remains a core part of protecting vulnerable patients and maintaining system resilience
Eligibility: No Major Changes This Year
The Joint Committee on Vaccination and Immunisation (JCVI) has kept the same eligible cohorts for 2026/27, meaning practices can plan with confidence and continuity. Key groups include:
- Pregnant women (from 1 September 2026)
- Children aged 2–3 years, plus all primary and secondary school‑aged children up to Year 11
- Children in clinical risk groups from 6 months to under 18 years
- Adults aged 65+ (from 1 October 2026)
- Adults aged 18–64 in clinical risk groups
- Residents in long‑stay care homes
- Carers, including those receiving carer’s allowance
- Close contacts of immunocompromised individuals
- Frontline social care workers without employer‑led vaccination schemes
- Frontline healthcare workers (employer‑led offer)
This stability in eligibility should help practices streamline recall systems and reduce administrative burden.
Timing and Delivery Expectations
The programme follows the same seasonal structure as previous years:
- 1 September 2026 – vaccination begins for pregnant women and early‑years children.
- 1 October 2026 – adult cohorts commence.
- End of November 2026 – recommended completion point for most vaccinations, though delivery can continue until 31 March 2027.
NHS England will issue further operational guidance, but practices are expected to plan for increased uptake compared with 2025/26. Providers are encouraged to ensure a “100% offer” to all eligible groups
Vaccine Types for 2026/27
JCVI has reviewed the evidence and confirmed that all preferred adult vaccines for 2026/27 are trivalent. Notable updates include:
- For adults 65+, cell‑cultured IIVc is now considered equivalent to adjuvanted (aIIV), high‑dose (IIV‑HD), and recombinant (IIVr) vaccines.
- For adults 50–59 in clinical risk groups, IIV‑HD may be used off‑label.
- Egg‑based vaccines (IIVe) should only be used for under‑65s if preferred vaccines are unavailable.
This gives practices more flexibility in ordering and stock management, especially where supply constraints arise.
The school‑based programme continues unchanged, covering Reception to Year 11. Children aged 2–3 years will continue to be vaccinated in general practice.
A decision on whether pharmacies will again vaccinate 2–3‑year‑olds is pending evaluation of the 2025/26 service.
Integration with COVID‑19 Vaccination
For the first time, NHS England has published a combined COVID‑19 and adult influenza vaccination service specification for 2026/27. Practices may deliver flu alone or both programmes. Key updates include:
- Individual practices can now deliver COVID‑19 vaccinations without forming a PCN grouping.
- COVID‑19 vaccinations can be recorded directly in GPIT systems, aligning with other vaccination services.
This alignment should reduce administrative friction and support smoother co‑delivery during the autumn/winter campaign.
What This Means for General Practice
1. Earlier planning will pay off
With eligibility unchanged and vaccine options clarified, practices can begin recall planning, stock ordering, and workforce scheduling earlier than usual.
2. Expect strong emphasis on uptake
National messaging stresses the need to vaccinate more people than in 2025/26, particularly in high‑risk groups. Practices may want to review last year’s uptake data and identify gaps.
3. Continue focusing on vulnerable groups
Pregnant women, older adults, and those with chronic conditions remain priority cohorts — and often the hardest to reach.
4. Align flu and COVID‑19 delivery where possible
Co‑administration may improve efficiency and uptake, especially in older adults and clinical risk groups.
Final Thoughts
The 2026/27 flu programme brings stability in eligibility, clearer vaccine guidance, and closer alignment with COVID‑19 vaccination delivery. For general practice, the focus now is on maximising uptake, reducing winter pressures, and ensuring vulnerable patients are protected well ahead of peak flu season
Stay ahead of the game and join us on our flu update on the 14th July 2026
References National flu Immunisation Programme 2026 to 2027 letter
